TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04382391

Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms

Cause of deathStaffing, sites or logistics Automatic label, confidence 0.9, unverified. How labels are made.
“A total of 21 patients were enrolled in the study resulting in 97 total collected specimen time points. Patient recruitment was halted due to greatly decreased numbers of patient hospitalizations for Covid-19.”

The sponsor’s own words in the registry.

Life of this trial

202020212022202320242025Registered2020-04-14Started2020-05-15Primary completion2022-08-22Stopped2023-04-13Results posted2024-05-01

Vital statistics

Status
Terminated
Phase
Na
Sponsor
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Sponsor type
University, hospital or other
Conditions
COVID; Corona Virus Infection; Respiratory Failure; Respiratory Distress Syndrome, Adult; ARDS, Human; SARS (Severe Acute Respiratory Syndrome)
Interventions
gammaCore® Sapphire (non-invasive vagus nerve stimulator); Standard of care therapies
Participants
21
Sites
2
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.